6AMGN : Amgen Unusual Options Activity For February 12
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 66% bearish. Among these notable options, 6 are puts, totaling $210,150, and 3 are calls, amounting to ...
7BMY : Bristol-Myers Squibb Unusual Options Activity
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
Stocktwits on MSN7h
Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes
Shares of Neuphoria Therapeutics Inc. soared more than 11% in premarket trading on Wednesday, propelling the micro-cap ...
NeuroOne projects FY 2025 revenue growth of up to 190% with Zimmer Biomet partnership
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...
Thiogenesis Announces Commencement of OTCQX Trading in the U.S.
Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing disulfides that drive the production of critically ...
OTC Markets Group Welcomes Thiogenesis Therapeutics, Corp. to OTCQX
About OTC Markets Group Inc. OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the ...
TMCnet1d
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
The Investor’s obligation to purchase Shares is subject to a number of conditions, including that the Company file a registration statement with the Securities and Exchange Commission (the “ SEC ”) ...
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011
RLF-TD011 has previously received orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for the treatment of EB. The Company also intends to seek qualified infectious disease ...
Cadrenal Therapeutics Announces New Chief Medical Officer in Recent SEC Filing
Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.
Hoth Therapeutics expands at-the-market offering by $5 million
Hoth Therapeutics , Inc. (NASDAQ:HOTH), a biopharmaceutical company, announced today that it has increased the maximum aggregate offering price of its common stock by $5 million under its existing At ...
Initial public offerings scheduled to debut next week
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Laredo Morning Times5d
New Hampshire man is 2nd person known to be living with a pig kidney
His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...